Abstract
The c-Jun transcription factor is a highly unstable oncoprotein. Several ubiquitin ligases mediate c-Jun degradation. However, c-Jun can be stabilized once it is phosphorylated at the N-terminus by c-Jun N-terminal kinases (JNKs) or other protein kinases. This phosphorylation decreases c-Jun ubiquitination and degradation. The underlying mechanism for this phenomenon is still unknown. Here, we show that receptor for activated C-kinase 1 (Rack1) can bind with c-Jun and ubiquitin ligase Fbw7 to form a complex. When c-Jun is phosphorylated at the N-terminus, c-Jun is released from the complex and cannot be ubiquitinated by Fbw7, which leads to increased stabilization and accumulation of c-Jun. These results reveal that Rack1 has a very important role in tumorigenesis by maintaining the stability of c-Jun that has been phosphorylated at its N-terminus by JNKs or other kinases.
Similar content being viewed by others
References
Berns H, Humar R, Hengerer B, Kiefer FN, Battegay EJ . (2000). RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J 14: 2549–2558.
Bernstein LR, Colburn NH . (1989). AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244: 566–569.
Binetruy B, Smeal T, Karin M . (1991). Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351: 122–127.
Cao XX, Xu JD, Liu XL, Xu JW, Wang WJ, Li QQ et al. (2009a). RACK1: A superior independent predictor for poor clinical outcome in breast cancer. Int J Cancer 127: 1172–1179.
Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Wang WJ et al. (2009b). RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Res Treat 123: 375–386.
Cho YY, Tang F, Yao K, Lu C, Zhu F, Zheng D et al. (2009). Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation. Cancer Res 69: 272–281.
Clark GJ, Cox AD, Graham SM, Der CJ . (1995). Biological assays for Ras transformation. Methods Enzymol 255: 395–412.
Dong Z, Colburn NH . (1994). AP-1: a molecular target for prevention of carcinogenesis. In: Srivastava S, Lippman SM, Hong WK, Mulshine JL (eds). Early Detection of Cancer. Futura Publishing Corp: Armonk, NY, pp 123–130.
Eferl R, Wagner EF . (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev 3: 859–868.
Egidy G, Jule S, Bosse P, Bernex F, Geffrotin C, Vincent-Naulleau S et al. (2008). Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation. Mol Cancer 7: 34.
Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC et al. (2004). Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306: 271–275.
Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP . (2007). Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 26: 131–143.
Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL . (2007). RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 25: 207–217.
Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z . (2005). RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell 19: 309–320.
Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11: 447–460.
Musti AM, Treier M, Bohmann D . (1997). Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400–402.
Nagashio R, Sato Y, Matsumoto T, Kageyama T, Satoh Y, Shinichiro R et al. (2009). Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas. Lung Cancer 69: 54–59.
Nateri AS, Riera-Sans L, Da Costa C, Behrens A . (2004). The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303: 1374–1378.
Papavassiliou AG, Treier M, Bohmann D . (1995). Intramolecular signal transduction in c-Jun. EMBO J 14: 2014–2019.
Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R et al. (2007). The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 9: 765–774.
Schechtman D, Mochly-Rosen D . (2001). Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339–6347.
Schubbert S, Shannon K, Bollag G . (2007). Hyperactive Ras in developmental disorders and cancer. Nat Rev 7: 295–308.
Sengupta J, Nilsson J, Gursky R, Spahn CM, Nissen P, Frank J . (2004). Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat Struct Mol Biol 11: 957–962.
Shaulian E, Karin M . (2001). AP-1 in cell proliferation and survival. Oncogene 20: 2390–2400.
Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M . (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494–496.
Stambolic V, Woodgett JR . (1994). Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303: 701–704.
Thornton C, Tang KC, Phamluong K, Luong K, Vagts A, Nikanjam D et al. (2004). Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization. J Biol Chem 279: 31357–31364.
Vomastek T, Iwanicki MP, Schaeffer HJ, Tarcsafalvi A, Parsons JT, Weber MJ . (2007). RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility. Mol Cell Biol 27: 8296–8305.
Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L et al. (2008). Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 7: 1639–1650.
Wei W, Jin J, Schlisio S, Harper JW, Kaelin Jr WG . (2005). The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8: 25–33.
Weiss C, Schneider S, Wagner EF, Zhang X, Seto E, Bohmann D . (2003). JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J 22: 3686–3695.
Welcker M, Clurman BE . (2008). FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev 8: 83–93.
Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ et al. (2004). Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303: 1371–1374.
Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R et al. (1999). Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proceedings of the National Academy of Sciences of the United States of America 96: 9827–9832.
Yu JY, DeRuiter SL, Turner DL . (2002). RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 99: 6047–6052.
Zhang W, Cheng GZ, Gong J, Hermanto U, Zong CS, Chan J et al. (2008). RACK1 and CIS mediate the degradation of BimEL in cancer cells. J Biol Chem 283: 16416–16426.
Acknowledgements
We thank Dr Wang Luhai and Dr Ronai Ze’ev for providing the HA-FL-Rack1, HA-WD1-4-Rack1 and HA-WD5-7-Rack1 vectors and Dr Wei Wenyi for providing the Flag-wt-c-Jun, Flag-ΔJNK-c-Jun, Flag-AF-c-Jun and Flag-AF-ΔJNK-c-Jun plasmids. We also thank Dr Bohmann Dirk for providing the c-JunAla and c-JunAsp mutant c-Jun plasmids. This study was supported by The Hormel Foundation and National Institutes of Health grants CA077646, CA111536, CA120388, ES016548 and R37 CA081064.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Zhang, J., Zhu, F., Li, X. et al. Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation. Oncogene 31, 1835–1844 (2012). https://doi.org/10.1038/onc.2011.369
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.369
- Springer Nature Limited
Keywords
This article is cited by
-
RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin
Cell Death & Disease (2023)
-
Clinical significance of FBXW7 loss of function in human cancers
Molecular Cancer (2022)
-
Dual functions of Rack1 in regulating Hedgehog pathway
Cell Death & Differentiation (2020)
-
Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1
Oncogene (2014)
-
RACK1, a clue to the diagnosis of cutaneous melanomas in horses
BMC Veterinary Research (2012)